P. Punthasee et al. / Tetrahedron Letters 51 (2010) 1713–1716
1715
I
Cl
O
O
N
O
I
O
N
N
N
Me
Cl
BuNH2
R
NH
N
N
NH
N
N
O
Base
23
CH Cl , DIPEA, RNH
N
2
2
2
5
rt
O
Bu
O
N
O
O
N
N
NHBu
9
Bu
Ph
N
N
Ph
N
N
H
N
H
N
N
N
H
N
N
24
25
a
9
, 78%
14, 69%a
15, 62%
Scheme 4. A plausible mechanistic pathway.
O
O
O
OMe
N
N
N
O
We also thank Dr. Paitoon Rashatasakhon, of the Chemistry Depart-
ment, Chulalongkorn University and Dr. Zhou-Kui Wan of Pfizer INc.,
Cambridge, MA, USA, for useful and interesting discussions.
N
N
N
1
6, 68%b
17, 0%
18, 49%
O
N
N
O
N
OEt
OEt
O
N
Supplementary data
OMe
OMe
NEt2
Supplementary data (experimental details and characterization
N
N
1
9, 87%a
20, 57%a
21, 44%
a
o
The reaction was carried out at 45 C
References and notes
b
o
The reaction was carried out at 80 C and DCE was used as the solvent.
1.
(a) Chan, J. H.; Hong, J. S.; Kuyper, L. F.; Jones, M. L.; Baccanari, D. P.; Tansik, R.
L.; Boytos, C. M.; Rudolph, S. K.; Brown, A. D. J. Heterocycl. Chem. 1997, 34, 145;
Scheme 2. Nucleophile scope.
(
b) Gackenheimer, S. L.; Schaus, J. M.; Gehlert, D. R. J. Pharmacol. Exp. Ther. 1996,
32, 113; (c) Dempcy, R. O.; Skibo, E. B. Biochemistry 1991, 30, 8480; (d)
Drogeand, N.; Kemi-Kalieforretning, A. Nordisk-Droge. 18113; Patent, N.A.,
7
1965; Chem. Abstr. 1965, 63, 18113.; (e) Witt, A.; Bergman, J. Curr. Org. Chem.
2
003, 7, 659. and references cited therein; (f) Larksarp, C.; Alper, H. J. Org. Chem.
O
N
O
N
2000, 65, 2773. and references cited therein.
N
Me
Cl
I
2. (a) Koepfly, J. B.; Mead, J. F.; Brockman, J. A., Jr. J. Am. Chem. Soc. 1947, 69, 1837;
(b) Jiang, S.; Zeng, Q.; Gettayacamin, M.; Tungtaeng, A.; Wannaying, S.; Lim, A.;
Hansukjariya, P.; Okunji, C. O.; Zhu, S.; Fang, D. Antimicrob. Agents Chemother.
2005, 49, 1169.
OH
N
NH
DIPEA, CH Cl , rt, 1 h
2
2
3
4
.
.
Comis, R. L. Oncologist 2005, 10, 467–470.
For representative examples, see: (a) Logé, C.; Testard, A.; Thiéry, V.; Lozach, O.;
Blairvacq, M.; Robert, J.-M.; Meijer, L.; Besson, T. Eur. J. Med. Chem. 2008, 43,
5
OH
echinozolinone, 22
H N
2
1
469–1477; (b) Ouyang, G. P.; Zhang, P. Q.; Xu, G. F.; Song, B. A.; Yang, S.; Jin, L.
8
1%
H.; Xue, W.; Hu, D. Y.; Lu, P.; Chen, Z. Molecules 2006, 11, 383; (c) Milad, B.;
Abdallah, M.; Djaffar, B.; Meriem, M.; Jacques, B. Heterocycl. Commun. 2004, 10,
2
Scheme 3. Synthesis of echinozolinone.
69; (d) Testard, A.; Loge, C.; Leger, B.; Robert, J.-M.; Lozach, O.; Blairvacq, M.;
Meijer, L.; Thiéry, V.; Besson, T. Bioorg. Med. Chem. Lett. 2006, 16, 3419; For
representative reviews on the synthesis of quinazolinones, see: (e) Connolly, D.
J.; Cusack, D.; O’Sullivan, T. P.; Guiry, P. J. Tetrahedron 2005, 61, 10153; (f)
Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787–9826.
Mechanistically, we hypothesize that the Mukaiyama reagent
first activates the N atom of the quinazolinone at the 3 position
leading to the formation of a pyridinium-quinazolinone intermedi-
ate 23 (Scheme 4). Attack of the primary amine on the amide moi-
ety results in the ring opening product, enamine 24. Cyclization
followed by elimination of an aminopyridinium generates the ob-
served product 9.
In conclusion, a new synthetic method to 3-alkylquinazolin-4-
ones has been developed employing Mukaiyama’s reagent as a
coupling agent. This reaction offers several advantages including
mild conditions, less by-product formation, high compatibility as
well as the use of an inexpensive, commercially available activator.
Further studies on the scope of the Mukaiyama reagent promoted
C–N bond formation as well as mechanistic investigations are un-
der study and will be reported in due course.
5. (a) Wissner, A.; Floyd, M. B.; Johnson, B. D.; Fraser, H.; Ingalls, C.; Nittoli, T.;
Dushin, R. G.; Discafani, C.; Nilakantan, R.; Marini, J.; Ravi, M.; Cheung, K.; Tan,
X.; Musto, S.; Annable, T.; Siegel, M. M.; Loganzo, F. J. Med. Chem. 2005, 48,
7560; (b) Mishani, E.; Abourbeh, G.; Jacobson, O.; Dissoki, S.; Daniel, R. B.;
Rozen, Y.; Shaul, M.; Levitzki, A. J. Med. Chem. 2005, 48, 5337; (c) Domarkas, J.;
Dudouit, F.; Williams, C.; Qiyu, Q.; Banerjee, R.; Brahimi, F.; Jean-Claude, B. J. J.
Med. Chem. 2006, 49, 3544.
(a) Wan, Z.-K.; Wacharasindhu, S.; Levins, C.; Lin, M.; Tabei, K.; Mansour, T. S. J.
Org. Chem. 2007, 72, 10194; (b) Wan, Z.-K.; Wacharasindhu, S.; Binnum, E.;
Mansour, T. Org. Lett. 2006, 8, 2425–2428; (c) Wacharasindhu, S.; Bardhan, S.;
Wan, Z.-K.; Tabei, K.; Mansour, T. S. J. Am. Chem. Soc. 2009, 131, 4174–4175.
Jackson, H.; Davies, P.; Bock, M. Nature 1968, 218, 977.
6
.
7
8
.
.
Montalbetti, C.; Falque, V. Tetrahedron 2005, 61, 10827.
9. (a) Bald, E.; Saigo, K.; Mukaiyama, T. Chem. Lett. 1975, 1163–1164; (b)
Mukaiyama, T. Angew. Chem., Int. Ed. Engl. 1979, 18, 707–721; (c) Huang, H.;
Iwasawa, N.; Mukaiyama, T. Chem. Lett. 1984, 1465–1466.
0. The HMBC spectrum of 9 showed correlations between H-1 and C-2 and C-3.
0
1
For additional details, please see the Supplementary data.
Acknowledgements
O
1'
3
N
2
'
ThefacultyofScience (RESA1B1-6)andRatchadaphiseksomphot
Endowment Fund, Chulalongkorn University and the Thailand Re-
search Fund (DIG-5180020) are gratefully acknowledged for finan-
cial support. We are grateful to Dr. Polkit Sangvanich, Chemistry
Department, Chulalongkorn University for HRMS measurements.
9
2
N
1
1. Upon completion of our studies, Yang and co-workers reported an analogous
synthesis using HATU: Xiao, Z.; Yang, M. G.; Li, P.; Carter, P. H. Org. Lett. 2009, 6,
1421.